Archive

Lung cancer – urgent action required to get back on track

Written by Christine Clark | 3 Feb 2022

Two recent reports show how hard lung cancer outcomes have been impacted as a result of the covid-19 pandemic, according to Professor Robert Rintoul, chair of the UK… read more.

Lung cancer screening and its implications

Written by Christine Clark | 19 Jul 2019

Professor Bob Steele CBE (Dundee, UK) discusses the potential implementation of a National Screening Programme in the UK, and the view post-NELSON, as well as highlighting the next steps in… read more.

Translational oncology symposium

Written by Christine Clark | 18 Jul 2019

The use of tyrosine kinase inhibitors (TKIs) in the treatment of ALK-positive NSCLC is now well-established. Professor Ross Camidge (University of Colorado Cancer Centre, Denver, USA) described the lessons that… read more.

Mesothelioma trials update

Written by Christine Clark | 10 Jul 2019

Dr Popat gives an update of the ongoing studies in mesothelioma in the UK

UK impact of trial data

Written by Christine Clark | 8 Jul 2019

Dr Fiona McDonald (London, UK) discusses radical treatment for oligo metastatic NSCLC and if it should be the standard of care and Professor James Spicer (London, UK), the session Chair, gives… read more.

Translational oncology: Tumour mutational burden and exploitation of DNA repair

Written by Christine Clark | 5 Jul 2019

Professor Ahmed gives an overview of one of the sessions in the BTOG Translational Oncology Symposium.

PACIFIC and beyond – the promise of immunotherapy

Written by Christine Clark | 10 May 2019

Correvio Pharma has resubmitted a New Drug Application (NDA) to the US FDA seeking approval for Brinavess (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of adult patients with recent onset atrial fibrillation (AF).

IASLC 2011 Report – The rivalry between cisplatin and carboplatin goes on: BTOG2 Trial

Written by Lorraine Carolan | 18 Jan 2012

by Dr Sunil Upadhyay – At the recently held 14th World Conference on Lung Cancer in Amsterdam, on behalf of the investigators, the randomised phase III clinical trial… read more.

IASLC World Congress on Lung Cancer 2011: Advances in the Treatment of Lung Cancer

Written by Lorraine Carolan | 18 Jan 2012

Foreward by Dr Sanjay Popat (pictured). The 14th Annual Scientific Meeting of the IASLC has now closed. Held in Amsterdam at the beginning of July 2011, the annual… read more.

Archive

Subscribe for our mailing list

Follow Us